合成MRI差值直方图分析评估脑膜瘤分级与细胞增殖
高、低级别组间多个参数差异有统计学意义,单个参数诊断分级AUC为0.65-0.79,联合模型AUC达0.88,且多个参数与Ki-67指数相关。
要点
- 合成MRI差值直方图参数有潜力作为脑膜瘤分级和增殖评估的生物标志物。
- 高、低级别脑膜瘤间多个PD、T1、T2直方图参数存在显著差异。
- 联合SyMRI模型诊断分级AUC达0.88,优于单个参数模型。
核心结论
- 合成MRI差值直方图参数有潜力作为脑膜瘤分级和细胞增殖评估的生物标志物。
研究设计与样本
- 计算对比前后直方图参数的绝对差值(dα = 增强后HP - 增强前HP)和相对差值(dα% = [增强后HP - 增强前HP]/增强前HP),其中α为T1、T2或质子密度(PD)。
- 参考标准为脑膜瘤病理分级和Ki-67表达。
关键影像表现/征象
- 高级别脑膜瘤PD偏度、增强后T1能量和总能量、增强后T2 IQR、平均绝对偏差(MAD)和稳健MAD(rMAD)、增强后PD偏度、dPD方差、IQR、MAD和rMAD、dPD%方差、IQR、MAD和rMAD均较高(P < .05)。
- 高级别脑膜瘤PD中位数和90百分位数较低(P < .05)。
诊断标准与关键数值
- 单个合成MRI直方图参数诊断脑膜瘤分级的AUC范围为0.65-0.79。
- 联合模型中合成MRI模型性能最佳(AUC = 0.88),优于单个模型(P < .05)。
临床应用与阅片要点
- 可基于合成MRI差值直方图参数辅助脑膜瘤分级和增殖评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To investigate the potential of delta histogram analysis of synthetic MRI (SyMRI) for predicting meningioma grade and cellular proliferation. Materials and Methods In this prospective study from February 2022 to October 2023, consecutive participants scheduled for conventional MRI and SyMRI were enrolled. Histogram parameters (HPs) were obtained with whole-tumor volume analysis. Delta histogram parameters, including absolute (dα = postcontrast HP - precontrast HP) and relative delta HPs (dα% = [postcontrast HP - precontrast HP]/precontrast HP), where α = T1, T2, or proton density (PD), were calculated. The Mann-Whitney U test was used to compare HPs between high- and low-grade groups. Receiver operating characteristic curve and multiple logistic regression analysis, the DeLong test, and integrated discrimination improvement were used to evaluate diagnostic efficacy of the HPs and models. Spearman rank correlation coefficients analyzed the correlations between HPs and Ki-67 expression. Results Ninety-five participants with meningioma (mean age, 58 years ± 13 [SD]; 28 male) were enrolled in the study. Participants with high-grade meningiomas had greater PD skewness; postcontrast T1 energy and total energy; postcontrast T2 IQR, mean absolute deviation (MAD), and robust MAD (rMAD); postcontrast PD skewness; dPD variance, IQR, MAD, and rMAD; and dPD% variance, IQR, MAD, and rMAD and lower PD median and 90th percentile (P < .05). These single SyMRI HPs demonstrated moderate diagnostic accuracy in grading meningioma (area under the receiver operating characteristic curve [AUC], range: 0.65-0.79). Among the combined models, the SyMRI model achieved the best performance (AUC = 0.88), outperforming single models (P < .05). Multiple SyMRI HPs were correlated with the Ki-67 index (P < .05). Conclusion Delta HPs from SyMRI demonstrate potential as biomarkers for meningioma grading and proliferation assessment. Keywords: CNS, Brain/Brain Stem, Meningioma, Synthetic MRI, Delta Histogram Analysis, Neoplasm Grading, Ki-67 Antigen Supplemental material is available for this article. © RSNA, 2026.
引用
- Li Y, Chen Y, Sun M, et al. Delta Histogram Analysis of Synthetic MRI for Evaluating Grade and Cellular Proliferation of Meningioma. Radiol Imaging Cancer. 2026. PMID: 42212928. doi:10.1148/rycan.250419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。